Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAurobindopharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Like Lupin, Aurobindo Pharma from pharma space: Bandopadhyay

      Sudip Bandopadhya, Market Expert likes Lupin and Aurobindo Pharma from the pharma space.

    • Sell Aurobindo Pharma, PSU Banks; buy Bata: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may sell Aurobindo Pharma and PSU Banks including Andhra Bank, Canara Bank, and State Bank of India and advises buying Bata India.

    • Short Aurobindo Pharma, Shriram Transport; pick GAIL: Thacker

      Mitesh Thacker of miteshthacker.com is of the view that one may short Aurobindo Pharma and Shriram Transport Finance and pick GAIL India.

    • Invest in Lupin, Tech Mahindra positional buy: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may invest in Lupin while Tech Mahindra is a positional buy.

    • Motilal Oswal sees 52% upside in Aurobindo, upgrades Kaveri Seed

      Motilal Oswal says it is time to add exposure to Aurobindo Pharma as it sees negligible impact of lawsuit filed in the US related to price collusion and cartelisation for two generic drugs. Motilal has also upgraded Kaveri Seed to buy as it feels the outlook is improving after the quarterly earnings.

    • Buy TVS Motor, Tata Comm; sell pharma stocks on rally: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy TVS Motor and Tata Communications and sell pharma stocks including Aurobindo Pharma, Sun Pharma and Lupin on rallies.

    • Buy Aurobindo Pharma, Tata Communications: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com recommends buying Aurobindo Pharma and Tata Communications.

    • Buy Reliance Capital 440 Call, says VK Sharma

      According to VK Sharma of HDFC Securities, one may buy Reliance Capital 440 Call.

    • Tulsian upbeat on Motherson Sumi, Bharat Forge, Crompton

      SP Tulsian of sptulsian.com shares his rationale behind his bullish view on Crompton Greaves, Motherson Sumi and Bharat Forge.

    • Super 17: Top stocks the market gurus are bullish on for 2017

      On CNBC-TV18's special show 'Super17', market experts SP Tulsian, Prakash Diwan, Dipan Mehta and Daljeet Singh Kohli outlined a list of 17 stocks they are bullish on for the coming year 2017.

    • Tulsian on realty, pharma & Rel Cap-Zee stks post radio biz deal

      In an interview to CNBC-TV18 SP Tulsian of sptulsian.com shared his outlook on pharmaceutical and real estate sectors. He also discussed his take on Reliance Capital's sale of radio and TV businesses to Zee Entertainment and what it means for these stocks.

    • Sell Nagarjuna Construction, BHEL; buy Aurobindo Pharma: Gujral

      According to Ashwani Gujral of ashwanigujral.com, one can sell Nagarjuna Construction and BHEL and buy Aurobindo Pharma.

    • Buy Engineers India; sell Sun TV, Bharat Financial: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Engineers India and sell Sun TV and Bharat Financial Inclusion.

    • Sell Aurobindo Pharma, Kotak Bank; buy Tata Global: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can sell Aurobindo Pharma and Kotak Mahindra Bank and buy Tata Global Beverage.

    • Buy, sell, hold: 5 stock that analysts are watching out

      Credit Suisse maintains underperform call on GAIL with target unchanged at Rs 310 per share as transmission segment robust and polymer ramp-up promising.

    • Here are some stock ideas from Prakash Diwan

      In an interview to CNBC-TV18 Prakash Diwan, Market Expert at Altamount Capital Management shared his reading and outlook on the market.

    • Prefer Cipla, Aurobindo Pharma: Gaurang Shah

      Gaurang Shah of Geojit BNP Paribas is of the view that one may prefer Cipla and Aurobindo Pharma from pharma space.

    • Prefer Aurobindo Pharma, says Gaurang Shah

      Gaurang Shah of Geojit BNP Paribas is of the view that one may prefer Aurobindo Pharma.

    • Sell Hero Moto, Aurobindo Pharma; buy Dabur: Ashwani Gujral

      According to Ashwani Gujral of ashwanigujral.com, oen can sell Hero MotoCorp and Aurobindo Pharma and buy Dabur India.

    • Sell Aurobindo Pharma, Yes Bank: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com recommends selling Aurobindo Pharma and Yes Bank.

    • Tulsian tells: Why he is +ve on Glenmark, Aurobindo, Bliss GVS

      In an interview with CNBC-TV18, market expert SP Tulsian gave his stock picks for the day and shared his market outlook.

    • Remain invested in Aurobindo Pharma: Sharmila Joshi

      Sharmila Joshi of sharmilajoshi.com is of the view that one may remain invested in Aurobindo Pharma.Sharmila Joshi of sharmilajoshi.com is of the view that one may remain invested in Aurobindo Pharma.

    • Diwali rocket stocks: 10 large caps to buy in Samvat 2073

      ICICI Direct sees Sensex EPS to grow 16.4 percent YoY to Rs 1600 in FY17 and then witness growth of 17.5 percent YoY in FY18 to Rs 1880. It has set a one year forward target of 31000 for the Sensex and 9400 for the Nifty.

    • Tulsian's take on Eicher, other cos that reported Q2 earnings

      In an interview to CNBC-TV18 SP Tulsian of sptulsian.com shares his take on companies that declared their quarterly earnings like Strides Shasun and its peers, Kansai Nerolac and Colgate among others. He also shares his outlook on Eicher Motors.

    • Sell Tata Motors, Tata Steel, Auro Pharma; buy Hero Moto: Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling Tata Motors, Tata Steel, Aurobindo Pharma and Adani Ports and advises buying Hero MotoCorp.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347